| Dr Joseph J Furlin, MD | |
|
133 E Brush Hill Rd Ste 308, Elmhurst, IL 60126-5662 | |
| (331) 221-9006 | |
| Not Available |
| Full Name | Dr Joseph J Furlin |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 27 Years |
| Location | 133 E Brush Hill Rd Ste 308, Elmhurst, Illinois |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316988389 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | 036102544 (Illinois) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Elmhurst Memorial Hospital | Elmhurst, IL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Elmhurst Memorial Healthcare | 9638168602 | 182 |
News Archive
The Alzheimer Society of Ontario congratulates Ontario's re-elected Liberal Government and urges them to make good on their healthcare commitments.
An interdisciplinary team of researchers from Columbia University, led by Ken Shepard, professor of electrical engineering and biomedical engineering at Columbia Engineering and including Virginia W. Cornish, Helena Rubinstein Professor of Chemistry, and Lars Dietrich, assistant professor of biological sciences, has won a prestigious $1 million three-year grant from the W. M. Keck Foundation to advance their research in combining biological components with solid-state electronics, creating new systems that exploit the advantages of both.
Ahead of next week's International AIDS Conference in Durban, South Africa, the Global Fund to Fight AIDS, Tuberculosis and Malaria today released results that show a significant increase in the number of people being treated for HIV.
Delcath Systems, Inc. today announced that the Company has submitted the remaining modules of its 505(b)(2) New Drug Application (NDA) for its proprietary chemosaturation system to the U.S. Food & Drug Administration (FDA). The Company had previously submitted Module 4, consisting of literature based non-clinical data, to the FDA in late April 2010. The Company is seeking an indication for the percutaneous intra-arterial administration of melphalan hydrochloride for use in the treatment of patients with metastatic melanoma in the liver.
Each year, the American Association of Neurological Surgeons (AANS) recognizes a neurosurgeon who has made significant contributions to the neurosurgical specialty through leadership, service and dedication.
› Verified 3 days ago
| Entity Name | Elmhurst Memorial Healthcare |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457493454 PECOS PAC ID: 9638168602 Enrollment ID: O20040506001298 |
News Archive
The Alzheimer Society of Ontario congratulates Ontario's re-elected Liberal Government and urges them to make good on their healthcare commitments.
An interdisciplinary team of researchers from Columbia University, led by Ken Shepard, professor of electrical engineering and biomedical engineering at Columbia Engineering and including Virginia W. Cornish, Helena Rubinstein Professor of Chemistry, and Lars Dietrich, assistant professor of biological sciences, has won a prestigious $1 million three-year grant from the W. M. Keck Foundation to advance their research in combining biological components with solid-state electronics, creating new systems that exploit the advantages of both.
Ahead of next week's International AIDS Conference in Durban, South Africa, the Global Fund to Fight AIDS, Tuberculosis and Malaria today released results that show a significant increase in the number of people being treated for HIV.
Delcath Systems, Inc. today announced that the Company has submitted the remaining modules of its 505(b)(2) New Drug Application (NDA) for its proprietary chemosaturation system to the U.S. Food & Drug Administration (FDA). The Company had previously submitted Module 4, consisting of literature based non-clinical data, to the FDA in late April 2010. The Company is seeking an indication for the percutaneous intra-arterial administration of melphalan hydrochloride for use in the treatment of patients with metastatic melanoma in the liver.
Each year, the American Association of Neurological Surgeons (AANS) recognizes a neurosurgeon who has made significant contributions to the neurosurgical specialty through leadership, service and dedication.
› Verified 3 days ago
| Entity Name | Northshore University Healthsystem Faculty Practice Associates |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497701882 PECOS PAC ID: 2163334699 Enrollment ID: O20040524000118 |
News Archive
The Alzheimer Society of Ontario congratulates Ontario's re-elected Liberal Government and urges them to make good on their healthcare commitments.
An interdisciplinary team of researchers from Columbia University, led by Ken Shepard, professor of electrical engineering and biomedical engineering at Columbia Engineering and including Virginia W. Cornish, Helena Rubinstein Professor of Chemistry, and Lars Dietrich, assistant professor of biological sciences, has won a prestigious $1 million three-year grant from the W. M. Keck Foundation to advance their research in combining biological components with solid-state electronics, creating new systems that exploit the advantages of both.
Ahead of next week's International AIDS Conference in Durban, South Africa, the Global Fund to Fight AIDS, Tuberculosis and Malaria today released results that show a significant increase in the number of people being treated for HIV.
Delcath Systems, Inc. today announced that the Company has submitted the remaining modules of its 505(b)(2) New Drug Application (NDA) for its proprietary chemosaturation system to the U.S. Food & Drug Administration (FDA). The Company had previously submitted Module 4, consisting of literature based non-clinical data, to the FDA in late April 2010. The Company is seeking an indication for the percutaneous intra-arterial administration of melphalan hydrochloride for use in the treatment of patients with metastatic melanoma in the liver.
Each year, the American Association of Neurological Surgeons (AANS) recognizes a neurosurgeon who has made significant contributions to the neurosurgical specialty through leadership, service and dedication.
› Verified 3 days ago
| Entity Name | Joseph J Furlin Md Sc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184898686 PECOS PAC ID: 4981884707 Enrollment ID: O20110211000276 |
News Archive
The Alzheimer Society of Ontario congratulates Ontario's re-elected Liberal Government and urges them to make good on their healthcare commitments.
An interdisciplinary team of researchers from Columbia University, led by Ken Shepard, professor of electrical engineering and biomedical engineering at Columbia Engineering and including Virginia W. Cornish, Helena Rubinstein Professor of Chemistry, and Lars Dietrich, assistant professor of biological sciences, has won a prestigious $1 million three-year grant from the W. M. Keck Foundation to advance their research in combining biological components with solid-state electronics, creating new systems that exploit the advantages of both.
Ahead of next week's International AIDS Conference in Durban, South Africa, the Global Fund to Fight AIDS, Tuberculosis and Malaria today released results that show a significant increase in the number of people being treated for HIV.
Delcath Systems, Inc. today announced that the Company has submitted the remaining modules of its 505(b)(2) New Drug Application (NDA) for its proprietary chemosaturation system to the U.S. Food & Drug Administration (FDA). The Company had previously submitted Module 4, consisting of literature based non-clinical data, to the FDA in late April 2010. The Company is seeking an indication for the percutaneous intra-arterial administration of melphalan hydrochloride for use in the treatment of patients with metastatic melanoma in the liver.
Each year, the American Association of Neurological Surgeons (AANS) recognizes a neurosurgeon who has made significant contributions to the neurosurgical specialty through leadership, service and dedication.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joseph J Furlin, MD 4201 Winfield Rd Fl 3, Warrenville, IL 60555-4025 Ph: (331) 221-6377 | Dr Joseph J Furlin, MD 133 E Brush Hill Rd Ste 308, Elmhurst, IL 60126-5662 Ph: (331) 221-9006 |
News Archive
The Alzheimer Society of Ontario congratulates Ontario's re-elected Liberal Government and urges them to make good on their healthcare commitments.
An interdisciplinary team of researchers from Columbia University, led by Ken Shepard, professor of electrical engineering and biomedical engineering at Columbia Engineering and including Virginia W. Cornish, Helena Rubinstein Professor of Chemistry, and Lars Dietrich, assistant professor of biological sciences, has won a prestigious $1 million three-year grant from the W. M. Keck Foundation to advance their research in combining biological components with solid-state electronics, creating new systems that exploit the advantages of both.
Ahead of next week's International AIDS Conference in Durban, South Africa, the Global Fund to Fight AIDS, Tuberculosis and Malaria today released results that show a significant increase in the number of people being treated for HIV.
Delcath Systems, Inc. today announced that the Company has submitted the remaining modules of its 505(b)(2) New Drug Application (NDA) for its proprietary chemosaturation system to the U.S. Food & Drug Administration (FDA). The Company had previously submitted Module 4, consisting of literature based non-clinical data, to the FDA in late April 2010. The Company is seeking an indication for the percutaneous intra-arterial administration of melphalan hydrochloride for use in the treatment of patients with metastatic melanoma in the liver.
Each year, the American Association of Neurological Surgeons (AANS) recognizes a neurosurgeon who has made significant contributions to the neurosurgical specialty through leadership, service and dedication.
› Verified 3 days ago
Dr. Shawn Michael Davies, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 533 W North Ave Ste 101, Elmhurst, IL 60126 Phone: 630-530-1501 Fax: 630-530-1908 | |
Dr. William A Fitzmaurice Jr., M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 360 W Butterfield Rd, Suite 250, Elmhurst, IL 60126 Phone: 630-832-4210 Fax: 630-832-8110 | |
Ms. Michelle Albovias, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1200 S York St Ste 3250, Elmhurst, IL 60126 Phone: 331-221-1700 Fax: 331-221-2729 | |
Roger A Macduff, D O Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1200 S York St Ste 2000, Elmhurst, IL 60126 Phone: 331-221-9002 Fax: 331-221-2749 | |
Dr. Janaki Nandam, D.O. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 133 E Brush Hill Rd Ste 400, Elmhurst, IL 60126 Phone: 630-432-6340 Fax: 630-873-8841 | |
Dr. Evelyn E Chen, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 360 W Butterfield Rd, Suite 250, Elmhurst, IL 60126 Phone: 630-832-4210 Fax: 630-832-8110 | |
Armando A San Juan, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 133 E Brush Hill Rd Ste 308, Elmhurst, IL 60126 Phone: 331-221-9006 Fax: 331-221-2734 |